Merck & Eisai announce Welireg plus Lenvima meets primary endpoint of PFS in certain previously treated patients with advanced RCC: Rahway, New Jersey Wednesday, October 29, 2025, ...

NPPA allowed discontinuation of 21 scheduled formulations in FY25: Gireesh Babu, New Delhi Wednesday, October 29, 2025, 08:00 ...

D, a new standard in deuterated reagents for pharma innovation: Tewksbury, Massachusetts Wednesday, October 29, 2025, 12:00 Hrs [IST] Camb ...

EU approves Alexion’s Koselugo for plexiform neurofibromas in adults with neurofibromatosis type 1: Cambridge, UK Wednesday, October 29, 2025, 11:00 Hrs [IST] Alexion, AstraZene ...

Akums breaks ground for its first overseas manufacturing facility in Zambia: Our Bureau, Bengaluru Tuesday, October 28, 2025, ...

Roche’s phase III INShore study of Gazyva/Gazyvaro in children and young adults with idiopathic nephrotic syndrome meets its primary endpoints: Basel Wednesday, October 29, 2025 ...

GSK and Empirico ink license agreement for clinical-stage, first-in-class oligonucleotide candidate to treat respiratory diseases: London, UK Wednesday, October 29, 2025, 09:00 Hr ...

MvPI reviews 47,614 medical device associated adverse event cases in the past 10 years: Shardul Nautiyal, Mumbai Wednesday, October 29, 2025, 08:00 Hrs [IST] The Materiovigilance ...

HDDA seeks uniform pricing to end patient mistrust and financial strain: Peethaambaran Kunnathoor, Chennai Wednesday, October 29, 2025, 08:00 Hrs [IST] The Haryana Drug Dealers As ...

Industry stresses on backward integration, collaboration & indigenous sourcing to reduce import dependence: Nandita Vijayasimha, Bengaluru Wednesday, October 29, 2025, 08:00 Hrs [ ...

Karnataka appoints FSDA Commissioner as Compounding Authority for offences related to drugs & cosmetics: Nandita Vijayasimha, Bengaluru Wednesday, October 29, 2025, 08:00 Hrs [IST ...

Our Bureau, Bengaluru Tuesday, October 28, 2025, 16:15 Hrs [IST] ...